etidronate has been researched along with Chronic Kidney Failure in 10 studies
Etidronic Acid: A diphosphonate which affects calcium metabolism. It inhibits ectopic calcification and slows down bone resorption and bone turnover.
etidronic acid : A 1,1-bis(phosphonic acid) that is (ethane-1,1-diyl)bis(phosphonic acid) having a hydroxy substituent at the 1-position. It inhibits the formation, growth, and dissolution of hydroxyapatite crystals by chemisorption to calcium phosphate surfaces.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Treatment with etidronate, 400 mg daily, induced total regression of severe, disabling periarticular calcifications during a treatment period of 42 months in a patient with chronic kidney disease on dialysis treatment." | 1.36 | [Regression of severe periarticular calcifications during treatment with bisphosphonate in a dialysis patient]. ( Larsen, NA; Obad, D; Pedersen, EB, 2010) |
| "Bisphosphonates may be effective in treating calciphylaxis and arteriosclerosis obliterans by reducing the formation of ectopic calcification around blood vessels." | 1.34 | Intractable wounds caused by calcific uremic arteriolopathy treated with bisphosphonates. ( Hanafusa, T; Katayama, I; Nishimura, Y; Tani, M; Umegaki, N; Yamaguchi, Y, 2007) |
| "Etidronate was well tolerated during the study." | 1.32 | Effects of cyclic intermittent etidronate therapy on coronary artery calcification in patients receiving long-term hemodialysis. ( Akiba, T; Aoki, T; Majima, K; Nihei, H; Nitta, K; Suzuki, K; Uchida, K; Watanabe, R, 2004) |
| "These appearances are frequently seen in renal osteodystrophy but are uncommon in malignant disease." | 1.26 | Absent kidney sign associated with symmetrical and uniformly increased uptake of radiopharmaceutical by the skeleton. ( Boyle, IT; Fogelman, I; Greig, WR; McKillop, JH, 1977) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (30.00) | 18.7374 |
| 1990's | 2 (20.00) | 18.2507 |
| 2000's | 4 (40.00) | 29.6817 |
| 2010's | 1 (10.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| de Graaf, P | 1 |
| Schicht, IM | 1 |
| Pauwels, EK | 2 |
| Souverijn, JH | 1 |
| de Graeff, J | 1 |
| Obad, D | 1 |
| Larsen, NA | 1 |
| Pedersen, EB | 1 |
| Nitta, K | 1 |
| Akiba, T | 1 |
| Suzuki, K | 1 |
| Uchida, K | 1 |
| Watanabe, R | 1 |
| Majima, K | 1 |
| Aoki, T | 1 |
| Nihei, H | 1 |
| Ariyoshi, T | 1 |
| Eishi, K | 1 |
| Sakamoto, I | 1 |
| Matsukuma, S | 1 |
| Odate, T | 1 |
| Mori, H | 1 |
| Okada, Y | 1 |
| Tanaka, Y | 1 |
| Hanafusa, T | 1 |
| Yamaguchi, Y | 1 |
| Tani, M | 1 |
| Umegaki, N | 1 |
| Nishimura, Y | 1 |
| Katayama, I | 1 |
| Paterson, CR | 1 |
| Feely, J | 1 |
| Plotast, H | 1 |
| Grzegorzewska, AE | 1 |
| Junik, R | 1 |
| Sowinski, J | 1 |
| Gembicki, M | 1 |
| Fogelman, I | 1 |
| McKillop, JH | 1 |
| Boyle, IT | 1 |
| Greig, WR | 1 |
| de Jonge, FA | 1 |
| Hamdy, NA | 1 |
1 review available for etidronate and Chronic Kidney Failure
| Article | Year |
|---|---|
Scintigraphy in the clinical evaluation of disorders of mineral and skeletal metabolism in renal failure.
Topics: Amyloidosis; Calcinosis; Chronic Kidney Disease-Mineral and Bone Disorder; Etidronic Acid; Humans; K | 1991 |
1 trial available for etidronate and Chronic Kidney Failure
| Article | Year |
|---|---|
Effect of etidronic acid on arterial calcification in dialysis patients.
Topics: Aged; Aorta, Abdominal; Aorta, Thoracic; Bone Density Conservation Agents; Calcinosis; Coronary Vess | 2006 |
8 other studies available for etidronate and Chronic Kidney Failure
| Article | Year |
|---|---|
Bone scintigraphy in uremic pulmonary calcification.
Topics: Adolescent; Adult; Bone and Bones; Calcinosis; Etidronic Acid; Female; Humans; Kidney Failure, Chron | 1979 |
[Regression of severe periarticular calcifications during treatment with bisphosphonate in a dialysis patient].
Topics: Bone Density Conservation Agents; Calcinosis; Etidronic Acid; Humans; Kidney Failure, Chronic; Male; | 2010 |
Effects of cyclic intermittent etidronate therapy on coronary artery calcification in patients receiving long-term hemodialysis.
Topics: Aged; Blood Chemical Analysis; Bone Density; Coronary Stenosis; Etidronic Acid; Female; Glycoprotein | 2004 |
Etidronate for the treatment of progressive tumoral calcinosis in hemodialysis patients.
Topics: Adult; Bone Density Conservation Agents; Calcinosis; Disease Progression; Etidronic Acid; Humans; Ki | 2007 |
Intractable wounds caused by calcific uremic arteriolopathy treated with bisphosphonates.
Topics: Calciphylaxis; Etidronic Acid; Humans; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; S | 2007 |
Vitamin D metabolites and analogues, diphosphonates, danazol, and bromocriptine.
Topics: Acromegaly; Bromocriptine; Calcitriol; Danazol; Endometriosis; Etidronic Acid; Female; Fibrocystic B | 1983 |
A comparison of bone scans in uremic patients treated with intermittent peritoneal dialysis or hemodialysis.
Topics: Adult; Bone and Bones; Chronic Kidney Disease-Mineral and Bone Disorder; Etidronic Acid; Female; Hum | 1996 |
Absent kidney sign associated with symmetrical and uniformly increased uptake of radiopharmaceutical by the skeleton.
Topics: Adolescent; Adult; Aged; Bone and Bones; Child; Chronic Kidney Disease-Mineral and Bone Disorder; Et | 1977 |